APH.L Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Mai 2024 @ 17:35):

Stats
Tagesvolumen	3.09M
Durchschnittsvolumen	1.03M
Marktkapitalisierung	178.87M
EPS	£0 ( 2024-04-09 )
Last Dividend	£1.184 ( 2023-06-22 )
Next Dividend	£0 ( N/A )
P/E	-33.10
ATR14	£0.114 (0.34%)

Volumen Korrelation

Lang: -0.18 (neutral)

Kurz: 0.15 (neutral)

Signal:(59.282) Neutral

Alliance Pharma PLC Korrelation

10 Am meisten positiv korreliert
RCN.L	0.919
XUEB.L	0.905
BIRG.L	0.905
AIBG.L	0.902
FOG.L	0.896
EBQ.L	0.885
NUM.L	0.883
DTY.L	0.881
EMAU.L	0.871
CLIN.L	0.867

10 Am meisten negativ korreliert
TEP.L	-0.906
3NIS.L	-0.896
LNGA.L	-0.885
GFIN.L	-0.884
INHC.L	-0.882
PTRO.L	-0.882
GIF.L	-0.882
BIDS.L	-0.878
ECHO.L	-0.872
PUR.L	-0.871

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Alliance Pharma PLC Korrelation - Währung/Rohstoff

0.81
( strong )

0.57
( weak )

-0.66
( moderate negative )

0.86
( strong )

0.45
( neutral )

-0.69
( moderate negative )

Alliance Pharma PLC Finanzdaten

Annual	2022
Umsatz:	£167.42M
Bruttogewinn:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2022
Umsatz:	£167.42M
Bruttogewinn:	£101.68M (60.74 %)
EPS:	£0.00170

FY	2021
Umsatz:	£163.21M
Bruttogewinn:	£109.45M (67.06 %)
EPS:	£0.0137

FY	2020
Umsatz:	£129.80M
Bruttogewinn:	£82.82M (63.80 %)
EPS:	£0.0154

Financial Reports:

No articles found.

Alliance Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0.592 (N/A)	£0 (N/A)	£1.184 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Alliance Pharma PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 6.61 - average (87.25%) | Divividend Growth Potential Score: 1.442 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.0700	2009-12-02
Last Dividend	£1.184	2023-06-22
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	£15.63	--
Avg. Dividend % Per Year	1.27%	--
Score	3	--
Div. Sustainability Score	6.61
Div.Growth Potential Score	1.442
Div. Directional Score	4.03	--

Next Divdend (Est)
(2024-10-14)

£1.255 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.00

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2009	£0.0700	2.33%
2010	£0.400	1.48%
2011	£0.650	2.11%
2012	£0.775	2.51%
2013	£0.853	2.67%
2014	£0.938	2.32%
2015	£1.033	2.79%
2016	£1.137	2.65%
2017	£1.250	2.75%
2018	£1.375	2.04%
2019	£1.513	2.30%
2020	£0.536	0.63%
2021	£2.20	2.50%
2022	£1.720	1.57%
2023	£1.184	2.17%
2024	£0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SDY.L	Dividend Knight	2023-08-10	Annually	33	2.31%
HWG.L	Dividend Knight	2023-09-21	Semi-Annually	32	0.78%
BGEO.L	Dividend Knight	2023-10-05	Annually	14	3.65%
WTAN.L	Dividend King	2023-08-24	Quarterly	53	1.48%
NEXS.L	Dividend Junior	2023-06-01	Annually	8	0.56%
EGY.L	Dividend King	2023-08-24	Quarterly	3	2.58%
SPO.L	Dividend Knight	2023-07-27	Sporadic	3	61.25%
JAGI.L	Dividend King	2023-07-13	Quarterly	27	2.39%
BSC.L	Dividend Knight	2023-10-05	Semi-Annually	20	5.24%
PHP.L	Dividend King	2023-07-06	Quarterly	28	2.84%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0415	1.500	-0.830	-1.245	[0 - 0.5]
returnOnAssetsTTM	-0.0137	1.200	-0.458	-0.550	[0 - 0.3]
returnOnEquityTTM	-0.0250	1.500	-1.389	-2.08	[0.1 - 1]
payoutRatioTTM	-1.315	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.931	0.800	5.35	4.28	[1 - 3]
quickRatioTTM	1.333	0.800	6.86	5.49	[0.8 - 2.5]
cashRatioTTM	0.533	1.500	8.15	10.00	[0.2 - 2]
debtRatioTTM	0.242	-1.500	5.96	-8.94	[0 - 0.6]
interestCoverageTTM	3.05	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0397	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.449	-1.500	8.20	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.516	1.000	4.74	4.74	[0.2 - 0.8]
operatingProfitMarginTTM	0.144	1.000	9.13	9.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.174	1.000	-0.143	-0.143	[0.2 - 2]
assetTurnoverTTM	0.331	0.800	-1.127	-0.901	[0.5 - 2]
Total Score				6.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-25.32	1.000	-2.66	0	[1 - 100]
returnOnEquityTTM	-0.0250	2.50	-0.893	-2.08	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0397	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	3.58	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0402	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	-1.315	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-47.87	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.31	0	[0.1 - 0.5]
Total Score				1.442

Alliance Pharma PLC

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.